Dr. Waugh's Lab Logo MCL Home David S. Waugh National Cancer Institute Home Page Dr. Waugh's Home Page Dr. Waugh's Research Summary Dr. Waugh's Publications Dr. Waugh's Staff Dr. Waugh's Structure Gallery Dr. Waugh's Technical Information
 
pDW363
 
 Description: This plasmid expression vector enables a protein of interest to be produced with a biotin acceptor peptide (BAP) fused directly to its N-terminus, or, alternatively, as a fusion to the C-terminus of E. coli maltose-binding protein with the BAP on its N-terminus.
   
 Origin: A derivative of pMal-C2 (New England Biolabs)
   
 Replicon: ColE1 (pBR322)
   
 Antibotic Resistance: Ampicillin
   
 Promotor: trc
   
 Inducer: IPTG (1 mM)
   
 Notes: pDW363 also overproduces biotin holoenzyme synthetase (BirA) to ensure efficient biotinylation of BAP-tagged proteins in vivo. Add biotin to the medium (50 mM) when cultivating cells that contain pDW363 or it derivatives.
   
 Literature Citations: Tsao, K.-L., DeBarbieri, B., Michel, H. and Waugh, D. S. (1996). A versatile plasmid expression vector for the production of biotinylated proteins by site-specific, enzymatic modification in Escherichia coli. Gene 169: 59-64; Schatz. P. J. (1993). Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Bio/Technology 11:1138-43.
   
 Nucleotide Sequence:  
   
   
MCL Bottom Navigation Bar MCL Home MCL Web Site Map MCL Contact Information MCL Web Disclaimer NCI-FCRDC Web Site NCI-CCR Web Site